Utilization of anti-HER2 regimens among HER2-positive metastatic breast cancer patients.

282Background: HER2-positive (+) metastatic breast cancer (mBC) has a poor prognosis and many patients require multiple lines of HER2 targeted regimens. This study aims to examine the treatment seq...